VistaGen Therapeutics Inc. raised about $2.3 million from its private placement to individual investors.
The California-based company sold about 1.8 million units for $1.25 apiece.
Each unit consisted of one unregistered common share and a warrant to buy 1 unregistered common stock for $1.50 per share.
The company intends to use the proceeds for general working capital purposes.
VistaGen develops and commercializes medicines for depression and other central nervous system disorders.